Global Continuous Glucose Monitoring Market (CGM) Market 2017 Industry Trends, Growth Rate with CAGR Analysis 2022: Abbott Laboratories, DexCom Incorporation, Medtronic

Continuous Glucose Monitoring SWOT Analysis And Forecast

Scope of the Report

The report titled “Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global CGM market. The report also gives an insight of the global CGM market by value, by penetration, by products, by components, by region, etc.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global CGM market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The competition in global CGM market is dominated by the two big players, DexCom Incorporation and Medtronic. Further, key players of the CGM market DexCom, Incorporation, Medtronic and Abbott Laboratories are also profiled with their financial information and respective business strategies.

Request For Sample Report @

Country Coverage

North America
Western Europe

Company Coverage

Abbott Laboratories
DexCom Incorporation

Executive Summary

Continuous Glucose Monitoring (CGM) is a small glucose sensor (electrodes) inserted under the skin that keeps in check the glucose levels in interstitial fluid. The sensor stays in body for several days to a week before being replaced. A transmitter that is placed on the body sends information about the level of glucose via radio waves from the sensor to a wireless monitor that could be in the form of a wristband or it could be an app on the smartphone that allows the patient to view their glucose measurements. The CGM system basically has been designed to target the type1 diabetic population, for the early detection of hypo and hyperglycemia. The CGM system is made of three parts: a wireless monitor (receiver), a transmitter and a sensor. The CGM market has several advantages and disadvantages.

Global CGM market has increased at a significant CAGR during the years 2014-2015 and projections are made that the market would rise in the next four years i.e. 2016-2020 tremendously. The CGM market is expected to increase due to increasing population with type1 diabetes, sedentary lifestyle, rising population with obesity, etc. Yet, the market faces some challenges such as, intense competition in the market, lack of penetration in type 2 diabetes, lack of reliability and accuracy in data.

 Complete Report Details @

Table Of Contents

  1. Executive Summary
  2. Introduction

2.1 Diabetes: An Overview
2.1.1 Types of Diabetes
2.1.2 Symptoms of Diabetes
2.1.3 Diagnosis of Diabetes
2.1.4 Treatment for Diabetes
2.1.5 Instruments/Gadgets/Apps to Manage Diabetes
2.1.6 Composition of Diabetes Device Market

2.2 Continuous Glucose Monitoring (CGM): An Overview
2.2.1 Advantages & Disadvantages of CGM

2.3 BGM v/s CGM
2.3.1 Blood Glucose Monitoring (BGM) v/s Continuous Glucose Monitoring (CGM)

  1. Global Market Analysis

3.1 Global Diabetes Market: An Analysis
3.1.1 Global Diabetic Population
3.1.2 Global Diabetic Population by Region

3.2 Global Diabetes Device Market: An Analysis
3.2.1 Global Diabetes Device Market/Glucose Monitoring Market by Value
3.2.2 Global Diabetes Device Market by Segments

3.3 Global CGM Market: An Analysis
3.3.1 Global CGM Market by Value
3.3.2 Global CGM Market by Segments
3.3.3 Global CGM Market by Regions

  1. Regional Market Analysis

4.1 North America CGM Market: An Analysis
4.1.1 North America CGM Market by Value
4.1.2 US Diabetic Population
4.1.3 US Diabetic Population by Diagnosis
4.1.4 US Diabetes Population by Segments
4.1.5 US Type 1 Diabetic Population on the Basis of Management
4.1.6 US CGM Market by Patient & Penetration

4.2 Western Europe CGM Market: An Analysis
4.2.1 Western Europe CGM Market by Value

4.3 China CGM Market: An Analysis
4.3.1 China CGM Market by Value
4.3.2 China CGM Market by Segments

  1. Market Dynamics

    5.1 Growth Drivers
5.1.1 Increasing Population with Diabetes
5.1.2 Expanding Treatment Market for Type 1 Diabetes
5.1.3 Rising Population with Obesity
5.1.4 Factors Driving Recommendation for CGM
5.1.5 Sedentary Lifestyle

    5.2 Challenges
      5.2.1 Barriers to CGM Adoption by Type 1 Diabetes Patients
5.2.2 Discontinuation of CGM Use
5.2.3 Lack of Penetration in Type 2 Diabetes
5.2.4 Intense Competition
5.2.5 Regulatory Risk

    5.3 Market Trends
5.3.1 Growing CGM Adoption
5.3.2 Smartphone Sales to End Users
5.3.3 CGM Penetration
5.3.4 The Reimbursement and Pricing Landscape
5.3.5 Innovation in CGM

  1. Competitive Landscape

6.1 Global Competitive Landscape
6.1.1 Global CGM Market Players by CGM System Pricing
6.1.2 Global CGM Market Players by CGM Product Features
6.1.3 Global CGM Market Players by Share

6.2 US Competitive Landscape
6.2.1 US CGM Market Players by CGM Product Features
6.2.2 US CGM Market Players by Share (Volume)
6.2.3 US CGM Market Players by Product Preference

  1. Company Profile

7.1 Abott Laboratories
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy

7.2 DexCom Incorporation
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy

7.3 Medtronic
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy


Buy This Report @                         



Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Author: Press Release

Publish your press release instantly without any paywall.

Share This Post On

Leave a Reply